Skip to main content
. 2021 Sep 20;9(9):1272. doi: 10.3390/biomedicines9091272

Table 4.

Combined results of Studies I-III.

miRNA DLB vs. CTRLs AD vs. CTRLs PD vs. CTRLs DLB vs. AD DLB vs. PD
n 59 vs. 51 28 vs. 51 24 vs. 51 59 vs. 28 59 vs. 24
let-7d-5p
expr change 1 0.25 1.81 0.98 0.14 0.28
dev range 2 0.05–1.16 1.74–1.84 0.61–1.29 0.03–0.62 0.04–1.91
p-value 3 0.08 0.102 0.17 0.006 0.15
miR-128-3p
expr change 0.26 1.38 0.38 0.19 0.87
dev range 0.05–1.45 0.79–2.4 0.3–0.49 0.06–0.61 0.69–1.13
p-value 0.106 0.57 0.0007 0.05 0.89
miR-132-5p
expr change 0.43 3.50 0.58 0.12 0.89
dev range 0.15–0.81 2.92–4.20 0.27–0.97 0.04–0.42 0.76–1.01
p-value 0.201 <0.0001 0.18 0.001 0.81
miR-139-5p
expr change 0.20 1.22 0.48 0.16 0.41
dev range 0.04–0.91 1.14–1.3 0.30–0.78 0.04–0.70 0.06–3.04
p-value 0.05 0.96 0.008 0.05 0.68
miR-142-3p
expr change 0.14 2.09 1.10 0.07 0.12
dev range 0.02–0.78 1.99–2.21 0.80–1.52 0.01–0.35 0.02–0.97
p-value 0.007 0.05 0.65 0.0005 0.05
miR-146a-5p
expr change 0.34 5.00 0.67 0.07 0.72
dev range 0.18–0.66 3.03–8.27 0.51–0.84 0.02–0.22 0.46–1.02
p-value 0.05 0.00013 0.41 0.0004 0.45
miR-150-5p
expr change 0.04 0.36 0.87 0.10 0.04
dev range 0.02–0.07 0.28–0.46 0.49–1.53 0.07–0.17 0.01–0.14
p-value <0.0001 0.1 0.69 0.01 <0.0001
miR-25-3p
expr change 0.47 3.76 0.71 0.13 0.83
dev range 0.22–1.00 2.38–5.93 0.49–1.1 0.04–0.42 0.67–1.09
p-value 0.23 0.0003 0.76 0.002 0.49
miR-26b-5p
expr change 0.18 1.65 1.54 0.09 0.11
dev range 0.03–1.07 1.12–1.80 1.24–1.92 0.01–0.68 0.02–0.86
p-value 0.05 0.05 0.05 0.001 0.008
miR-6747-3p
expr change 0.76 3.50 1.23 0.22 0.56
dev range 0.35–1.63 2.40–5.10 1.02–1.46 0.07–0.68 0.52–0.64
p-value 0.71 0.0006 0.29 0.05 0.09

1 expr change, expression change obtained by the ΔΔCt method after comparing two groups; 2 dev range, deviation range of the expression change; 3 p-value obtained by the Wilcoxon–Mann–Whitney followed by Dunn’s test for multiple corrections. Significant results are highlighted in bold.